231 related articles for article (PubMed ID: 10912661)
1. Continuous infusion of cholecystokinin leads to down-regulation of the cholecystokinin-A receptor in the rat pancreas.
Ohlsson B; Borg K; Mulder H; Rehfeld JF; Axelson J; Sundler F
Scand J Gastroenterol; 2000 Jun; 35(6):612-8. PubMed ID: 10912661
[TBL] [Abstract][Full Text] [Related]
2. The method of administration of cholecystokinin determines the effects evoked in the pancreas.
Ohlsson B; Borg K; Rehfeld JF; Axelson J; Sundler F
Pancreas; 2001 Jul; 23(1):94-101. PubMed ID: 11451154
[TBL] [Abstract][Full Text] [Related]
3. The effect of intermittent injections of CCK-8S and the CCK-A receptor antagonist devazepide on cell proliferation in exocrine rat pancreas.
Ohlsson B; Borg K; Rehfeld JF; Ihse I; Axelson J
Int J Pancreatol; 1998 Dec; 24(3):211-8. PubMed ID: 9873956
[TBL] [Abstract][Full Text] [Related]
4. Cholecystokinin does not affect the pancreatic contents of epidermal growth factor or its receptor.
Ohlsson B; Rehfeld JF; Sundler F
Pancreas; 2000 Nov; 21(4):385-91. PubMed ID: 11075993
[TBL] [Abstract][Full Text] [Related]
5. Time-course of the pancreatic changes following long-term stimulation or inhibition of the CCK-A receptor.
Ohlsson B; Axelson J; Sternby B; Rehfeld JF; Ihse I
Int J Pancreatol; 1995 Aug; 18(1):59-66. PubMed ID: 7594771
[TBL] [Abstract][Full Text] [Related]
6. CCK stimulates growth of both the pancreas and the liver.
Ohlsson B; Rehfeld JF; Axelson J
Int J Surg Investig; 1999; 1(1):47-54. PubMed ID: 11817337
[TBL] [Abstract][Full Text] [Related]
7. The changes in the rat parotid glands following total parenteral nutrition and pancreatico-biliary diversion are not mediated by cholecystokinin.
Axelson J; Fan BG; Ohlsson B; Rehfeld J; Ekelund M; Ihse I
Int J Pancreatol; 1996 Oct; 20(2):109-18. PubMed ID: 8968866
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of the influence of devazepide and CCK-8S on the intact and resected rat liver.
Ohlsson B; Rehfeld JF; Axelson J
Eur Surg Res; 1998; 30(6):378-84. PubMed ID: 9838229
[TBL] [Abstract][Full Text] [Related]
9. Total parenteral nutrition affects the tropic effect of cholecystokinin on the exocrine pancreas.
Fan BG; Axelson J; Sternby B; Rehfeld J; Ihse I; Ekelund M
Scand J Gastroenterol; 1997 Apr; 32(4):380-6. PubMed ID: 9140162
[TBL] [Abstract][Full Text] [Related]
10. Portacaval shunt increases the trophic effect of cholecystokinin on the rat pancreas.
Nylander AG; Chen D; Rehfeld JF; Håkanson R
Scand J Gastroenterol; 1993 Feb; 28(2):145-8. PubMed ID: 8441908
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of cholecystokinin-A receptor mRNA in pancreas and cholecystokinin-B receptor mRNA in oxyntic mucosa after porta-caval shunting in rats.
Nylander AG; von Friesen CP; Monstein HJ; Yamada H; Chen D; Boketoft A; Håkanson R
Pharmacol Toxicol; 1997 Mar; 80(3):147-51. PubMed ID: 9101588
[TBL] [Abstract][Full Text] [Related]
12. Devazepide-induced hyperplasia in the rat liver and bile ducts.
Ohlsson B; Axelson J; Rehfeld JF; Ihse I
Eur Surg Res; 1996; 28(4):299-305. PubMed ID: 8813655
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic atrophy in rats produced by the cholecystokinin-A receptor antagonist devazepide.
Nylander AG; Chen D; Ihse I; Rehfeld JF; Håkanson R
Scand J Gastroenterol; 1992 Sep; 27(9):743-7. PubMed ID: 1411279
[TBL] [Abstract][Full Text] [Related]
14. The trophic effect of cholecystokinin on the pancreas declines in rats on total parenteral nutrition.
Wu XM; Liao YW; Ji KQ; Li GF; Zang B
J Anim Physiol Anim Nutr (Berl); 2012 Apr; 96(2):214-9. PubMed ID: 21438927
[TBL] [Abstract][Full Text] [Related]
15. Peripheral cholecystokinin A and cholecystokinin B receptors mediate stimulation of gastric pepsinogen and acid secretion following intracerebroventricular injection of cholecystokinin-8-sulphate.
Blandizzi C; Lazzeri G; Carignani D; Colucci R; Baschiera F; Tognetti M; Placanica G; Del Tacca M
Ital J Gastroenterol Hepatol; 1999; 31(6):440-8. PubMed ID: 10575559
[TBL] [Abstract][Full Text] [Related]
16. Enterochromaffin-like cells in rat stomach respond to short-term infusion of high doses of cholecystokinin but not to long-term, sustained, moderate hyperCCKemia caused by continuous cholecystokinin infusion or pancreaticobiliary diversion.
Nylander AG; Chen D; Lilja I; Axelson J; Ihse I; Rehfeld JF; Sundler F; Håkanson R
Scand J Gastroenterol; 1993 Jan; 28(1):73-9. PubMed ID: 8430275
[TBL] [Abstract][Full Text] [Related]
17. Evidence that cholecystokinin induces immediate early gene expression in the brainstem, hypothalamus and amygdala of the rat by a CCKA receptor mechanism.
Day HE; McKnight AT; Poat JA; Hughes J
Neuropharmacology; 1994 Jun; 33(6):719-27. PubMed ID: 7936109
[TBL] [Abstract][Full Text] [Related]
18. The ratio between anionic and cationic trypsin in rat pancreas varies with CCK stimulation.
Borgström A; Axelson J; Ihse I; Rehfeld JF
Pancreas; 1995 Aug; 11(2):179-84. PubMed ID: 7479676
[TBL] [Abstract][Full Text] [Related]
19. Effects of endogenous and exogenous cholecystokinin and of infusion with the cholecystokinin antagonist L-364,718 on pancreatic and gastrointestinal growth.
Axelson J; Håkanson R; Ihse I; Lilja I; Rehfeld JF; Sundler F
Scand J Gastroenterol; 1990 May; 25(5):471-80. PubMed ID: 2359975
[TBL] [Abstract][Full Text] [Related]
20. High-affinity CCK-A receptors on the vagus nerve mediate CCK-stimulated pancreatic secretion in rats.
Li Y; Hao Y; Owyang C
Am J Physiol; 1997 Sep; 273(3 Pt 1):G679-85. PubMed ID: 9316472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
